AFP and hepatocellular carcinoma: The TPS model outperformed the BCLC stage and AJCC TNM stage in predicting OS and early recurrence of AFP‐negative HCC patients after liver resection, which might better assist surgeons in screening AFP‐negative HCC patients who may benefit from liver resection.